These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29941676)

  • 1. Detection of a novel, primate-specific 'kill switch' tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53.
    Nyce JW
    Endocr Relat Cancer; 2018 Nov; 25(11):R497-R517. PubMed ID: 29941676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific mechanisms of tumor suppression are fundamental drivers of vertebrate speciation: critical implications for the 'war on cancer'.
    Nyce JW
    Endocr Relat Cancer; 2019 Feb; 26(2):C1-C5. PubMed ID: 30400061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lex naturalis delineates components of a human-specific, adrenal androgen-dependent, p53-mediated 'kill switch' tumor suppression mechanism.
    Nyce JW
    Endocr Relat Cancer; 2020 Feb; 27(2):R51-R65. PubMed ID: 31815681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of the human-specific, p53-mediated "kill switch" tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation.
    Nyce J
    Cancer Drug Resist; 2019; 2(4):1207-1214. PubMed ID: 35582271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
    MacIndoe JH
    Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.
    Timmerman DM; Remmers TL; Hillenius S; Looijenga LHJ
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf
    Chapeau EA; Gembarska A; Durand EY; Mandon E; Estadieu C; Romanet V; Wiesmann M; Tiedt R; Lehar J; de Weck A; Rad R; Barys L; Jeay S; Ferretti S; Kauffmann A; Sutter E; Grevot A; Moulin P; Murakami M; Sellers WR; Hofmann F; Jensen MR
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3151-3156. PubMed ID: 28265066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very High Dehydroepiandrosterone Sulfate (DHEAS) in Serum of an Overweight Female Adolescent Without a Tumor.
    Iliev DI; Braun R; Sánchez-Guijo A; Hartmann M; Wudy SA; Heckmann D; Bruchelt G; Rösner A; Grosser G; Geyer J; Binder G
    Front Endocrinol (Lausanne); 2020; 11():240. PubMed ID: 32435230
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutant TP53 disrupts age-related accumulation patterns of somatic mutations in multiple cancer types.
    Zhang W; Flemington EK; Zhang K
    Cancer Genet; 2016 Sep; 209(9):376-380. PubMed ID: 27751354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
    Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
    J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutations in human cancer: database reassessment and prospects for the next decade.
    Leroy B; Anderson M; Soussi T
    Hum Mutat; 2014 Jun; 35(6):672-88. PubMed ID: 24665023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.
    Herzog A; Bian Y; Vander Broek R; Hall B; Coupar J; Cheng H; Sowers AL; Cook JD; Mitchell JB; Chen Z; Kulkarni AB; Van Waes C
    Clin Cancer Res; 2013 Jul; 19(14):3808-19. PubMed ID: 23640975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines.
    Hennebold JD; Daynes RA
    Endocrinology; 1994 Jul; 135(1):67-75. PubMed ID: 8013393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression.
    Węsierska-Gądek J
    Future Med Chem; 2018 Apr; 10(7):755-777. PubMed ID: 29569948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational processes shape the landscape of TP53 mutations in human cancer.
    Giacomelli AO; Yang X; Lintner RE; McFarland JM; Duby M; Kim J; Howard TP; Takeda DY; Ly SH; Kim E; Gannon HS; Hurhula B; Sharpe T; Goodale A; Fritchman B; Steelman S; Vazquez F; Tsherniak A; Aguirre AJ; Doench JG; Piccioni F; Roberts CWM; Meyerson M; Getz G; Johannessen CM; Root DE; Hahn WC
    Nat Genet; 2018 Oct; 50(10):1381-1387. PubMed ID: 30224644
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Shirole NH; Pal D; Kastenhuber ER; Senturk S; Boroda J; Pisterzi P; Miller M; Munoz G; Anderluh M; Ladanyi M; Lowe SW; Sordella R
    Elife; 2016 Oct; 5():. PubMed ID: 27759562
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman primates as models for human adrenal androgen production: function and dysfunction.
    Abbott DH; Bird IM
    Rev Endocr Metab Disord; 2009 Mar; 10(1):33-42. PubMed ID: 18683055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.